Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand? (2020)
- Authors:
- USP affiliated authors: FARIAS, KELEN CRISTINA RIBEIRO MALMEGRIM DE - FCFRP ; RODRIGUES, MARIA CAROLINA DE OLIVEIRA - FMRP
- Unidades: FCFRP; FMRP
- DOI: 10.3389/fimmu.2019.03044
- Subjects: TRANSPLANTES; CÉLULAS-TRONCO; DOENÇAS AUTOIMUNES; EDITORIAL
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Immunology
- ISSN: 1664-3224
- Volume/Número/Paginação/Ano: v. 10, art. 3044, 2020
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
FARIAS, Kelen Cristina Ribeiro Malmegrim de et al. Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand?. Frontiers in Immunology. Lausanne: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fimmu.2019.03044. Acesso em: 28 dez. 2025. , 2020 -
APA
Farias, K. C. R. M. de, Toubert, A., Farge, D., & Rodrigues, M. C. de O. (2020). Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand? Frontiers in Immunology. Lausanne: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.3389/fimmu.2019.03044 -
NLM
Farias KCRM de, Toubert A, Farge D, Rodrigues MC de O. Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand? [Internet]. Frontiers in Immunology. 2020 ; 10[citado 2025 dez. 28 ] Available from: https://doi.org/10.3389/fimmu.2019.03044 -
Vancouver
Farias KCRM de, Toubert A, Farge D, Rodrigues MC de O. Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand? [Internet]. Frontiers in Immunology. 2020 ; 10[citado 2025 dez. 28 ] Available from: https://doi.org/10.3389/fimmu.2019.03044 - New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement
- Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?
- Lower Insulin-Dose Adjusted A1c (IDAA1c) is associated with less complications in individuals with type 1 diabetes treated with hematopoetic stem-cell transplantation and conventional therapy
- Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?
- Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II
- Teplizumab in relatives at risk for type 1 diabetes. [Carta]
- Autologous hematopoietic stem cell transplantation for autoimmune diseases: from mechanistic insights to biomarkers
- New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement
- CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta]
- Thymus rejuvenation after autologous hematopoietic stem cell transplantation in patients with autoimmune diseases
Informações sobre o DOI: 10.3389/fimmu.2019.03044 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003032283.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
